Prognostic Factors for the Long-Term Survival after Hematopoietic Stem Cell Transplantation in Patients with Hodgkin Lymphoma |
| |
Authors: | Dariush KadkhodaMaryam NikoonezhadAhmad Reza BaghestaniSayeh ParkhidehZahra Momeni-VarposhtiAli Akbar Khadem Maboudi |
| |
Institution: | 1Department of Biostatistics, School of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.2Department of Immunology, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran.3Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran University of Medical Sciences, Tehran, Iran.4Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. |
| |
Abstract: | Objectives: This study investigated the possible prognostic factors for the long-term survival (Cure Rate) of Hodgkin Lymphoma patients who underwent HSCT. Methods: This retrospective cohort study analyzed 116 Patients diagnosed with Hodgkin Lymphoma who received autologous hematopoietic stem cell transplantation (Auto-HSCT) between the years 2007 and 2014 and followed up until 2017. The information regarding patients’ survival had been collected using phone calls, and their pre-transplant information was available in the archived documents. Prognostic effects were investigated using long-term survival models. Results: Patients with obesity had five times higher odds of long-term survival (cure) than the others (P=0.06). Also, the recurrence experience after HSCT negatively impacted the curing potential by 78% (P=0.05). Also, with 32 years as the change point, patients younger than 32 had 76% fewer odds of surviving long-term (P=0.03), and Poor transfused stem cell dose of CD34+ (<0.16 × 106 cells/ml) reduced the odds of long-term survival by 92% (P=0.01). Conclusion: According to the statistical models used in this study, obesity can increase the curing potential of Hodgkin lymphoma after transplantation. Meanwhile, aging, poor transfused CD34+ cells, and recurrence after HSCT were associated with lower survival following HSCT. |
| |
Keywords: | Hematologic Neoplasms Hodgkin lymphoma Survival Analysis cure rate |
|
| 点击此处可从《Asian Pacific journal of cancer prevention : APJCP》浏览原始摘要信息 |
| 点击此处可从《Asian Pacific journal of cancer prevention : APJCP》下载免费的PDF全文 |
|